Patheon Quick to Clinic viral vector services

Fact Sheet

Moving gene therapies from preclinical studies to clinical and commercial manufacturing is complex Journey that requires significant financial investment — and it’s filled with risks and challenges.

Using Thermo Fisher Scientific's end-to-end manufacturing service, we deliver high-performance, scalable, AAV and lentiviral vectors to clinics. As a result of this service, you can deliver therapy to clinics while de-risking timelines and global regulatory filings without additional or surprising out-of-pocket costs.